ID   AMPO_HUMAN              Reviewed;         819 AA.
AC   Q8N6M6; Q5T9B1; Q5T9B3; Q5T9B4; Q8WUL6; Q96M23; Q96SS1;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   28-JUN-2023, entry version 163.
DE   RecName: Full=Aminopeptidase O {ECO:0000305};
DE            Short=AP-O;
DE            EC=3.4.11.- {ECO:0000250|UniProtKB:P15144};
GN   Name=AOPEP {ECO:0000312|HGNC:HGNC:1361}; Synonyms=C9orf3, ONPEP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 178-819 (ISOFORM 4).
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 219-819 (ISOFORM 1).
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   RETRACTED PAPER.
RC   TISSUE=Brain;
RX   PubMed=15687497; DOI=10.1074/jbc.m413222200;
RA   Diaz-Perales A., Quesada V., Sanchez L.M., Ugalde A.P., Suarez M.F.,
RA   Fueyo A., Lopez-Otin C.;
RT   "Identification of human aminopeptidase O, a novel metalloprotease with
RT   structural similarity to aminopeptidase B and leukotriene A4 hydrolase.";
RL   J. Biol. Chem. 280:14310-14317(2005).
RN   [5]
RP   RETRACTION NOTICE OF PUBMED:15687497.
RX   PubMed=30808004; DOI=10.1074/jbc.w118.007327;
RA   Diaz-Perales A., Quesada V., Sanchez L.M., Ugalde A.P., Suarez M.F.,
RA   Fueyo A., Lopez-Otin C.;
RL   J. Biol. Chem. 294:1433-1433(2019).
RN   [6]
RP   VARIANTS DYT31 255-ARG--PHE-819 DEL; 259-TRP--PHE-819 DEL AND
RP   493-ARG--PHE-819 DEL, AND INVOLVEMENT IN DYT31.
RX   PubMed=34596301; DOI=10.1002/mds.28804;
RA   Zech M., Kumar K.R., Reining S., Reunert J., Tchan M., Riley L.G.,
RA   Drew A.P., Adam R.J., Berutti R., Biskup S., Derive N., Bakhtiari S.,
RA   Jin S.C., Kruer M.C., Bardakjian T., Gonzalez-Alegre P.,
RA   Keller Sarmiento I.J., Mencacci N.E., Lubbe S.J., Kurian M.A., Clot F.,
RA   Meneret A., de Sainte Agathe J.M., Fung V.S.C., Vidailhet M., Baumann M.,
RA   Marquardt T., Winkelmann J., Boesch S.;
RT   "Biallelic AOPEP loss-of-function variants cause progressive dystonia with
RT   prominent limb involvement.";
RL   Mov. Disord. 37:137-147(2022).
CC   -!- FUNCTION: Aminopeptidase which catalyzes the hydrolysis of amino acid
CC       residues from the N-terminus of peptide or protein substrates.
CC       {ECO:0000250|UniProtKB:P15144}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P15144};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P15144};
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q8BXQ6}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm
CC       {ECO:0000250|UniProtKB:Q8BXQ6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8N6M6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N6M6-2; Sequence=VSP_013161;
CC       Name=3;
CC         IsoId=Q8N6M6-3; Sequence=VSP_013162, VSP_013163;
CC       Name=4;
CC         IsoId=Q8N6M6-4; Sequence=VSP_013161, VSP_013164, VSP_013165;
CC   -!- DISEASE: Dystonia 31 (DYT31) [MIM:619565]: A form of dystonia, a
CC       disorder defined by the presence of sustained involuntary muscle
CC       contraction, often leading to abnormal postures. DYT31 is an autosomal
CC       recessive, progressive form with onset from childhood to young
CC       adulthood. Involuntary muscle twisting movements and postural
CC       abnormalities affect the upper and lower limbs, neck, face, and trunk.
CC       Some patients may have orofacial dyskinesia resulting in articulation
CC       and swallowing difficulties. {ECO:0000269|PubMed:34596301}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   -!- CAUTION: A paper describing the function, enzyme activity and
CC       expression patterns of this protein has been retracted due to concerns
CC       of image manipulation. {ECO:0000305|PubMed:15687497,
CC       ECO:0000305|PubMed:30808004}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH20194.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB55210.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ560639; CAD90259.1; -; mRNA.
DR   EMBL; AK027581; BAB55210.1; ALT_INIT; mRNA.
DR   EMBL; AK057450; BAB71491.1; -; mRNA.
DR   EMBL; AL157936; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353768; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354893; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC020194; AAH20194.1; ALT_INIT; mRNA.
DR   EMBL; BC029616; AAH29616.1; -; mRNA.
DR   CCDS; CCDS55327.1; -. [Q8N6M6-3]
DR   CCDS; CCDS55328.1; -. [Q8N6M6-1]
DR   CCDS; CCDS6713.1; -. [Q8N6M6-2]
DR   RefSeq; NP_001180258.1; NM_001193329.1. [Q8N6M6-1]
DR   RefSeq; NP_001180260.1; NM_001193331.2. [Q8N6M6-3]
DR   RefSeq; NP_116212.3; NM_032823.5. [Q8N6M6-2]
DR   RefSeq; XP_006717369.1; XM_006717306.1.
DR   RefSeq; XP_016870719.1; XM_017015230.1.
DR   RefSeq; XP_016870720.1; XM_017015231.1. [Q8N6M6-2]
DR   AlphaFoldDB; Q8N6M6; -.
DR   SMR; Q8N6M6; -.
DR   BioGRID; 124346; 73.
DR   IntAct; Q8N6M6; 16.
DR   MINT; Q8N6M6; -.
DR   STRING; 9606.ENSP00000364464; -.
DR   ChEMBL; CHEMBL3831223; -.
DR   MEROPS; M01.028; -.
DR   iPTMnet; Q8N6M6; -.
DR   PhosphoSitePlus; Q8N6M6; -.
DR   BioMuta; C9orf3; -.
DR   DMDM; 61211648; -.
DR   EPD; Q8N6M6; -.
DR   MassIVE; Q8N6M6; -.
DR   PaxDb; Q8N6M6; -.
DR   PeptideAtlas; Q8N6M6; -.
DR   ProteomicsDB; 72195; -. [Q8N6M6-1]
DR   ProteomicsDB; 72196; -. [Q8N6M6-2]
DR   ProteomicsDB; 72197; -. [Q8N6M6-3]
DR   ProteomicsDB; 72198; -. [Q8N6M6-4]
DR   Antibodypedia; 985; 98 antibodies from 19 providers.
DR   DNASU; 84909; -.
DR   Ensembl; ENST00000277198.6; ENSP00000277198.2; ENSG00000148120.18. [Q8N6M6-3]
DR   Ensembl; ENST00000297979.9; ENSP00000297979.5; ENSG00000148120.18. [Q8N6M6-2]
DR   Ensembl; ENST00000375315.8; ENSP00000364464.2; ENSG00000148120.18. [Q8N6M6-1]
DR   GeneID; 84909; -.
DR   KEGG; hsa:84909; -.
DR   MANE-Select; ENST00000375315.8; ENSP00000364464.2; NM_001193329.3; NP_001180258.1.
DR   UCSC; uc004aux.3; human. [Q8N6M6-1]
DR   AGR; HGNC:1361; -.
DR   CTD; 84909; -.
DR   DisGeNET; 84909; -.
DR   GeneCards; AOPEP; -.
DR   HGNC; HGNC:1361; AOPEP.
DR   HPA; ENSG00000148120; Low tissue specificity.
DR   MalaCards; AOPEP; -.
DR   MIM; 619565; phenotype.
DR   MIM; 619600; gene.
DR   neXtProt; NX_Q8N6M6; -.
DR   OpenTargets; ENSG00000148120; -.
DR   PharmGKB; PA25978; -.
DR   VEuPathDB; HostDB:ENSG00000148120; -.
DR   eggNOG; KOG1047; Eukaryota.
DR   GeneTree; ENSGT00940000155211; -.
DR   InParanoid; Q8N6M6; -.
DR   OMA; FARCSQA; -.
DR   OrthoDB; 3108672at2759; -.
DR   PhylomeDB; Q8N6M6; -.
DR   TreeFam; TF332004; -.
DR   PathwayCommons; Q8N6M6; -.
DR   Reactome; R-HSA-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   SABIO-RK; Q8N6M6; -.
DR   SignaLink; Q8N6M6; -.
DR   BioGRID-ORCS; 84909; 11 hits in 1143 CRISPR screens.
DR   ChiTaRS; C9orf3; human.
DR   GenomeRNAi; 84909; -.
DR   Pharos; Q8N6M6; Tbio.
DR   PRO; PR:Q8N6M6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q8N6M6; protein.
DR   Bgee; ENSG00000148120; Expressed in apex of heart and 149 other tissues.
DR   ExpressionAtlas; Q8N6M6; baseline and differential.
DR   Genevisible; Q8N6M6; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.2010.30; -; 1.
DR   Gene3D; 1.10.390.10; Neutral Protease Domain 2; 1.
DR   Gene3D; 1.25.40.320; Peptidase M1, leukotriene A4 hydrolase/aminopeptidase C-terminal domain; 1.
DR   Gene3D; 2.60.40.1730; tricorn interacting facor f3 domain; 1.
DR   InterPro; IPR042097; Aminopeptidase_N-like_N_sf.
DR   InterPro; IPR033577; AOPep.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR038502; M1_LTA-4_hydro/amino_C_sf.
DR   InterPro; IPR015211; Peptidase_M1_C.
DR   InterPro; IPR014782; Peptidase_M1_dom.
DR   InterPro; IPR027268; Peptidase_M4/M1_CTD_sf.
DR   PANTHER; PTHR46627; AMINOPEPTIDASE O; 1.
DR   PANTHER; PTHR46627:SF1; AMINOPEPTIDASE O; 1.
DR   Pfam; PF09127; Leuk-A4-hydro_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   SMART; SM01263; Leuk-A4-hydro_C; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF63737; Leukotriene A4 hydrolase N-terminal domain; 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aminopeptidase; Cytoplasm; Disease variant; Dystonia;
KW   Hydrolase; Metal-binding; Metalloprotease; Nucleus; Protease;
KW   Reference proteome; Zinc.
FT   CHAIN           1..819
FT                   /note="Aminopeptidase O"
FT                   /id="PRO_0000095091"
FT   MOTIF           689..699
FT                   /note="Nucleolar localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BXQ6"
FT   ACT_SITE        480
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P15144,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         479
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P15144"
FT   BINDING         483
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P15144"
FT   BINDING         502
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P15144"
FT   SITE            586
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P15144"
FT   VAR_SEQ         455..553
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013161"
FT   VAR_SEQ         555..565
FT                   /note="PSKDKTGHTSD -> FPHVGGCSGSFS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013162"
FT   VAR_SEQ         566..819
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013163"
FT   VAR_SEQ         774..784
FT                   /note="AMGVYLYGELM -> VGVIFQQMGIL (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013164"
FT   VAR_SEQ         785..819
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013165"
FT   VARIANT         179
FT                   /note="V -> A (in dbSNP:rs16911679)"
FT                   /id="VAR_021511"
FT   VARIANT         179
FT                   /note="V -> I (in dbSNP:rs16911679)"
FT                   /id="VAR_057053"
FT   VARIANT         255..819
FT                   /note="Missing (in DYT31)"
FT                   /evidence="ECO:0000269|PubMed:34596301"
FT                   /id="VAR_086438"
FT   VARIANT         255
FT                   /note="R -> Q (in dbSNP:rs16911681)"
FT                   /id="VAR_057054"
FT   VARIANT         259..819
FT                   /note="Missing (in DYT31)"
FT                   /evidence="ECO:0000269|PubMed:34596301"
FT                   /id="VAR_086439"
FT   VARIANT         386
FT                   /note="R -> C (in dbSNP:rs34557833)"
FT                   /id="VAR_057055"
FT   VARIANT         493..819
FT                   /note="Missing (in DYT31)"
FT                   /evidence="ECO:0000269|PubMed:34596301"
FT                   /id="VAR_086440"
SQ   SEQUENCE   819 AA;  93572 MW;  9EB4F19295B92674 CRC64;
     MDIQLDPARD DLPLMANTSH ILVKHYVLDL DVDFESQVIE GTIVLFLEDG NRFKKQNSSI
     EEACQSESNK ACKFGMPEPC HIPVTNARTF SSEMEYNDFA ICSKGEKDTS DKDGNHDNQE
     HASGISSSKY CCDTGNHGSE DFLLVLDCCD LSVLKVEEVD VAAVPGLEKF TRSPELTVVS
     EEFRNQIVRE LVTLPANRWR EQLDYYARCS QAPGCGELLF DTDTWSLQIR KTGAQTATDF
     PHAIRIWYKT KPEGRSVTWT SDQSGRPCVY TVGSPINNRA LFPCQEPPVA MSTWQATVRA
     AASFVVLMSG ENSAKPTQLW EECSSWYYYV TMPMPASTFT IAVGCWTEMK METWSSNDLA
     TERPFSPSEA NFRHVGVCSH MEYPCRFQNA SATTQEIIPH RVFAPVCLTG ACQETLLRLI
     PPCLSAAHSV LGAHPFSRLD VLIVPANFPS LGMASPHIMF LSQSILTGGN HLCGTRLCHE
     IAHAWFGLAI GARDWTEEWL SEGFATHLED VFWATAQQLA PYEAREQQEL RACLRWRRLQ
     DEMQCSPEEM QVLRPSKDKT GHTSDSGASV IKHGLNPEKI FMQVHYLKGY FLLRFLAKRL
     GDETYFSFLR KFVHTFHGQL ILSQDFLQML LENIPEEKRL ELSVENIYQD WLESSGIPKP
     LQRERRAGAE CGLARQVRAE VTKWIGVNRR PRKRKRREKE EVFEKLLPDQ LVLLLEHLLE
     QKTLSPRTLQ SLQRTYHLQD QDAEVRHRWC ELIVKHKFTK AYKSVERFLQ EDQAMGVYLY
     GELMVSEDAR QQQLARRCFE RTKEQMDRSS AQVVAEMLF
//
